Observational study on vascular infections
Official title: VIP - Vascular Infection Project : Prospective Multicentric Database on Vascular Infections
Run by University Hospital, Bordeaux · NCT06866535 · Data updated 2026-11-12
This study is trying to gather information on how different vascular infections are treated to help improve care for people dealing with these serious conditions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 1 site (Bordeaux) |
| Status | Recruiting |
| Started | May 10, 2022 |
| Main results expected | May 10, 2032 |
| Study ends | May 10, 2032 |
| Registry record updated | March 10, 2025 |
| Trial ID | NCT06866535 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older diagnosed with a vascular infection, whether native or prosthetic.
✕Probably not a fit
Patients under legal protection will not benefit from this study as they are excluded from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to create a prospective multicentric observational database to investigate various vascular infections, including aortitis and infections related to vascular grafts and endografts. It will collect clinical and paraclinical data regarding medical, surgical, anesthetic, and intensive care management of these infections. The goal is to better understand the management strategies and outcomes associated with these rare but severe conditions, which currently lack consensus in treatment approaches.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies and outcomes for patients suffering from vascular infections.
How similar studies have gone: While vascular infections are rare, previous studies have highlighted the need for better management strategies, indicating that this approach could yield valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥ 18 years-old; * all patients with a vascular infection, either native (aortitis, arteritis) or prosthetic (vascular graft, endograft and/or stent), * oral consent Exclusion Criteria: * patient under legal protection
Where it's running
-
CHU Bordeaux
Bordeaux, France Recruiting
Study contacts
- Study coordinator: Mathilde Puges, MD
- Email: mathilde.puges@chu-bordeaux.fr
- Phone: +335 56 79 55 36
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Aortic and Vascular Graft Infection Study: A Look at Causes and Outcomes
This study follows adults with suspected or confirmed infections of the aorta or vascular grafts to see what causes the infections and how they respond to treatment using blood tests, tissue samples, and imaging.
-
Vascular graft and endograft infections: outcomes and immune responses
This study tests how patients with suspected or diagnosed vascular graft or endograft infections, along with people getting planned implants and healthy donors, respond over time and what markers help diagnose infections.
-
Using Tocilizumab for treating aortitis in Giant Cell Arteritis
This study is testing if a new version of Tocilizumab can safely help people with Giant Cell Arteritis and active aortitis feel better while they are already on standard treatment.
-
Collection of tissue samples for vasculitis research
This study is collecting tissue samples from patients with vasculitis to see if they can help researchers understand the disease better and find new ways to diagnose and treat it.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.